131 related articles for article (PubMed ID: 3751588)
1. [Synthesis of octahydroindolo [2,3-a] quinolizine derivatives].
Xu JY; Zhu CL
Yao Xue Xue Bao; 1986 Feb; 21(2):102-8. PubMed ID: 3751588
[No Abstract] [Full Text] [Related]
2. [Synthesis of 1-ethyl-1,2,3,4,6,7-hexahydroindolo-[2,3a]-quinolizinium perchlorate, a key intermediate of vincamine].
Chen GX; Guo RK
Yao Xue Xue Bao; 1983 Jul; 18(7):507-13. PubMed ID: 6659953
[No Abstract] [Full Text] [Related]
3. [Synthesis and pharmacologic activity of 9-R-octahydroindolo[2,3-a]quinolazine].
Boido-Canu C; Boido V; Sparatore F; Sparatore A; Susanna V; Russo S; Cenicola ML; Marmo E
Farmaco Sci; 1988 Oct; 43(10):819-37. PubMed ID: 3266484
[TBL] [Abstract][Full Text] [Related]
4. A new enantioselective total synthesis of natural vincamine via an intramolecular Mannich reaction of an silyl enol ether.
Oppolzer W; Hauth H; Pfäffli P; Wenger R
Helv Chim Acta; 1977; 60(5):1801-10. PubMed ID: 893125
[No Abstract] [Full Text] [Related]
5. Syntheses of vinca alkaloids and related compounds. 104. A concise synthesis of (-)-vincapusine.
Moldvai I; Gati T; Szantay C; Szantay C
J Org Chem; 2006 May; 71(10):3768-72. PubMed ID: 16674048
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of vinca alkaloids and related compounds. Part 84. Sulfonamide derivatives of some vinca alkaloids with cardiovascular activity.
Moldvai I; Temesvári-Major E; Szántay C; Tóth G; Kárpáti E; Szántay C
Arch Pharm (Weinheim); 1997 Jun; 330(6):190-8. PubMed ID: 9264244
[TBL] [Abstract][Full Text] [Related]
7. Studies on the vincamine-papaverine association. i. biochemical investigations.
Costrini R; Galzigna L; Bianchi M; Nunziata A; Cattani L
Agressologie; 1978; 19(3):211-4. PubMed ID: 736220
[No Abstract] [Full Text] [Related]
8. [Vincamine in the therapy of cerebral vascular diseases in the aged].
De Candia O; Bartolucci E; Mancinella A; Baghiris D
Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
[No Abstract] [Full Text] [Related]
9. [Investigation of vasoactive agents with indole skeletons at Richter Ltd].
Kárpáti E; Bíró K; Kukorelli T
Acta Pharm Hung; 2002; 72(1):25-36. PubMed ID: 12426785
[TBL] [Abstract][Full Text] [Related]
10. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
Periti P; Periti G; Colombo Pirola L
Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
[No Abstract] [Full Text] [Related]
11. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
Fidetzis K; Brosteano R; Keller P
Med Welt; 1976 Jul; 27(29):1412-4. PubMed ID: 785150
[No Abstract] [Full Text] [Related]
12. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
Cacciatori D
Clin Ter; 1979 Jun; 89(5):473-82. PubMed ID: 535324
[No Abstract] [Full Text] [Related]
13. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
Ambrozi L; Bruck J; Tschabitscher H
Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
Desruelles J; Camart JF
LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
[No Abstract] [Full Text] [Related]
15. The synthesis of ethyl apovincaminate.
Lörincz C; Szász K; Kisfaludy L
Arzneimittelforschung; 1976; 26(10a):1907. PubMed ID: 1037211
[TBL] [Abstract][Full Text] [Related]
16. [Stereoselective synthesis of optically active vincamine].
Pfäffli P; Oppolzer W; Wenger R; Hauth H
Helv Chim Acta; 1975 Jun; 58(4):1131-45. PubMed ID: 1158740
[No Abstract] [Full Text] [Related]
17. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
Bartels H
Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
[No Abstract] [Full Text] [Related]
18. [Synthesis of quinolizine derivatives. 23. Synthesis of perhydrobenzo[c]-quinolizine and benzo[c] quinolizidine derivatives].
Akiba M; Oki S
Yakugaku Zasshi; 1970 Oct; 90(10):1193-200. PubMed ID: 5529348
[No Abstract] [Full Text] [Related]
19. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
Lanfranchi M; Magnani G; Sinforiani E; Casali R
Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
Linquette M
Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
